<DOC>
	<DOC>NCT00275925</DOC>
	<brief_summary>This study is aimed to evaluate the efficacy, safety and tolerability of oxcarbazepine monotherapy in adults with partial seizures.</brief_summary>
	<brief_title>Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>males and females, 18 70 years of age; diagnosis of epilepsy, partial seizures; ineffective or intolerable present therapy with 1 antiepileptic drug, or none of previous therapy with antiepileptic drugs progressive lesion of brain revealed by CT/MRI that performed no earlier than 2 years prior to screening; nonepileptic seizures; drug or alcohol dependence during a year prior to screening; Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>partial epilepsy, oxcarbazepine, adults</keyword>
</DOC>